Matglim PG 2mg/500mg/15mg Tablet SR
Marketer
JV Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Matglim PG 2mg/500mg/15mg Tablet SR
Glyciphage XR 2mg/500mg/15mg extended-release tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood sugar. Always follow your physician's prescribed dosage and duration for Glyciphage XR. Take it with food to prevent gastric discomfort. If a dose is missed, take it immediately unless the next dose is imminent; then, omit the missed dose and resume your usual schedule. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, inform your doctor about any kidney, liver, or heart conditions. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before treatment commences. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Matglim PG 2mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Matglim PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Matglim PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Matglim PG 2mg/500mg/15mg sustained-release tablet should be administered with food.
Common Side effects of Matglim PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Matglim PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Matglim PG 2mg/500mg/15mg Extended-Release Tablet with a meal.
How Matglim PG 2mg/500mg/15mg Tablet SR works:
Matglim PG 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple combination improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Matglim PG 2mg/500mg/15mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Matglim PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Matglim PG tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar conditions.
KidneyCAUTION
Exercise caution when administering Matglim PG 2mg/500mg/15mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician before use. The use of Matglim PG 2mg/500mg/15mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Matglim PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Matglim PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Matglim PG 2mg/500mg/15mg Tablet SR :
Should you forget to take your Matglim PG 2mg/500mg/15mg Tablet SR, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Matglim PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently